Page last updated: 2024-11-05

trihexyphenidyl and Brain Damage, Chronic

trihexyphenidyl has been researched along with Brain Damage, Chronic in 2 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research Excerpts

ExcerptRelevanceReference
"In older patients hemidystonia appeared within 6 months after injury."1.27Hemidystonia: a report of 22 patients and a review of the literature. ( Jankovic, J; Pettigrew, LC, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pettigrew, LC1
Jankovic, J1
Hader, M1

Other Studies

2 other studies available for trihexyphenidyl and Brain Damage, Chronic

ArticleYear
Hemidystonia: a report of 22 patients and a review of the literature.
    Journal of neurology, neurosurgery, and psychiatry, 1985, Volume: 48, Issue:7

    Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Brain Damage, Chronic; Brain Diseases; Brain Injuri

1985
Antiparkinsonism medication for the phenothiazine-induced pyramidal-extrapyramidal syndrome in elderly brain-damaged patients.
    Journal of the American Geriatrics Society, 1965, Volume: 13, Issue:10

    Topics: Aged; Brain Damage, Chronic; Chlorpromazine; Female; Humans; Male; Parkinson Disease; Perphenazine;

1965